Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BioNTech Clocked Massive Q1 Revenue Growth; Estimates COVID-19 Vaccine Revenues Of €12B

By: TalkMarkets
BioNTech SE reports Q1 FY21 revenues of €2.05 billion compared to €27.7 million a year ago. The increase was mainly due to rapidly increasing the supply of COVID-19 vaccine worldwide.
Related Stocks:
Biontech Se ADR Pfizer
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback